Edition:
India

Ascendis Pharma A/S (ASND.OQ)

ASND.OQ on NASDAQ Stock Exchange Global Select Market

151.00USD
2 Jul 2020
Change (% chg)

$-1.85 (-1.21%)
Prev Close
$152.85
Open
$153.51
Day's High
$154.98
Day's Low
$148.70
Volume
39,009
Avg. Vol
60,128
52-wk High
$158.76
52-wk Low
$90.06

Select another date:

Mon, Jun 22 2020

BRIEF-Ascendis Pharma Announces Presentation Of Preclinical Data For Transcon Il-2 Β/Γ At AACR Virtual Annual Meeting 2020

* ASCENDIS PHARMA A/S ANNOUNCES PRESENTATION OF PRECLINICAL DATA FOR TRANSCON IL-2 Β/Γ AT AACR VIRTUAL ANNUAL MEETING 2020 Source text for Eikon: Further company coverage:

BRIEF-Ascendis Reports Q1 Loss Per Share Of EUR 1.32

* ASCENDIS PHARMA - ON TRACK FOR FILING U.S. BLA FOR TRANSCON HGH IN Q2, ADVANCING MARKETING AUTHORISATION APPLICATION IN EUROPE TO Q3

BRIEF-Ascendis Pharma Announces Top-Line Data From Fixed Dose Portion Of Phase 2 Trial Demonstrating Potential Of Transcon PTH As Replacement Therapy For Hypoparathyroidism

* ASCENDIS PHARMA A/S ANNOUNCES TOP-LINE DATA FROM FIXED DOSE PORTION OF PHASE 2 TRIAL DEMONSTRATING POTENTIAL OF TRANSCON™ PTH AS A REPLACEMENT THERAPY FOR HYPOPARATHYROIDISM

BRIEF-Ascendis Pharma Continues To Monitor And Adapt To Impact Of COVID-19

* ASCENDIS PHARMA A/S REPORTS FULL-YEAR 2019 FINANCIAL RESULTS

Select another date: